Advances in lung imaging techniques for the treatment of respiratory disease

Drug Discovery Today: Therapeutic Strategies

Volumn 5, Issue 2, 2008, Pages 87-92

  Möller, Winfried ^a   Meyer, Gabriele ^b   Kreyling, Wolfgang G ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; KRYPTON 81M; RESPIRATORY TRACT AGENT; TECHNETIUM 99M; XENON 133;

AEROSOL; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LABELING; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; ECHO PLANAR IMAGING; FLOW RATE; GAMMA RADIATION; HUMAN; IMAGE QUALITY; INHALATION; INHALER; ISOTOPE LABELING; LUNG FIBROSIS; LUNG SCINTISCANNING; LUNG TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; RADIATION ATTENUATION; REPRODUCIBILITY; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; REVIEW; SCINTILLATION CAMERA; THORAX RADIOGRAPHY; TIDAL VOLUME;

EID: 63649160172     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2008.06.002     Document Type: Review

References (31)

1. Magnussen H. Inhalation therapy for bronchial asthma: strategies and targets. Curr. Opin. Pulm. Med. 9 (2003) S3-S7
2. Gonda I. Systemic delivery of drugs to humans via inhalation. J. Aerosol Med. 19 (2006) 47-53
3. ICRP Publication 66. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann. ICRP 24 (1994) 1-482
4. Bennett W.D., et al. Targeting delivery of aerosols to different lung regions. J. Aerosol Med. 15 (2002) 179-188
5. Brand P., et al. Peripheral deposition of alpha-protease inhibitor using commercial inhalation devices. Eur. Respir. J. 22 (2003) 263-267
6. Smaldone G.C., and Messina M.S. Flow limitation, cough, and patterns of aerosol deposition in humans. J. Appl. Physiol. 59 (1985) 515-520
7. Ilowite J.S., et al. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch. Environ. Health 44 (1989) 267-273
8. Möller W., et al. Deposition, retention and translocation of ultrafine particles from the central airways and lung periphery. Am. J. Respir. Crit. Care Med. 177 (2008) 426-432
9. 99mTc radiolabelled aerosol particles targeted to central human airways using planar gamma camera imaging. J. Aerosol Med., doi:10.1089/jamp.2007.0664, in press
10. Bennett W.D., et al. Regional deposition and retention of particles in shallow, inhaled boluses: effect of lung volume. J. Appl. Physiol. 86 (1999) 168-173
11. Fleming J.S. A technique for the absolute measurement of activity using a gamma camera and computer. Phys. Med. Biol. 24 (1979) 176-180
12. Parker R.P., et al. Basic Science of Nuclear Medicine (1984), Churchill Livingstone
13. Pitcairn G.R., and Newman S.L. Tissue attenuation corrections in gamma scintigraphy. J. Aerosol Med. 10 (1997) 187-198
14. Lee Z., et al. Usefulness and pitfalls of planar gamma-scintigraphy for measuring aerosol deposition in the lungs: a Monte Carlo investigation. J. Nucl. Med. 42 (2001) 1077-1083
15. Fleming J.S. A technique for using CT images in attenuation correction and quantification in SPECT. Nucl. Med. Commun. 10 (1989) 83-97
16. Eberl S., et al. SPECT imaging for radioaerosol deposition and clearance studies. J. Aerosol Med. 19 (2006) 8-20
17. Forge N.I., et al. Quantification of technetium-99m lung radioactivity from planar images. Eur. J. Nucl. Med. Mol. Imaging 20 (1993) 10-15
18. Macey D.J., and Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J. Nucl. Med. 23 (1982) 731-734
19. Fleming J.S., et al. A comparison of planar scintigraphy and SPECT measurement of total lung deposition of inhaled aerosol. J. Aerosol Med. 16 (2003) 9-19
20. Brand P., et al. Total deposition of therapeutic particles during spontaneous and controlled inhalations. J. Pharm. Sci. 89 (2000) 724-731
21. Gessler T., et al. Aerosolized vasodilators in pulmonary hypertension. J. Aerosol Med. 15 (2002) 117-122
22. Sahara M., et al. New insights in the treatment strategy for pulmonary arterial hypertension. Cardiovasc. Drugs Ther. 20 (2006) 377-386
23. Garcia-Contreras L., and Hickey A.J. Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy. Adv. Drug Deliv. Rev. 54 (2002) 1491-1504
24. Laube B.L. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir. Care 50 (2005) 1161-1176
25. Acerbi D., et al. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite(R) technology. Pulm. Pharmacol. Ther. 20 (2007) 290-303
26. Santolicandro A., et al. Imaging of ventilation in chronic obstructive pulmonary disease. J. Thorac. Imaging 1 (1986) 36-53
27. Jaffé A., et al. Routine ventilation scans in children with cystic fibrosis: diagnostic usefulness and prognostic value. Eur. J. Nucl. Med. 28 (2001) 1313-1318
28. 99mTc-Technegas and krypton-81 m ventilation scintigraphy: a comparison in known respiratory disease. Br. J. Radiol. 65 (1992) 1075-1082
29. Kauczor H.U., et al. Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 201 (1996) 564-568
30. Fain S.B., et al. Functional lung imaging using hyperpolarized gas MRI. J. Magn. Reson. Imaging 25 (2007) 910-923
31. Dhand R., and Mercier E. Effective inhaled drug administration to mechanically ventilated patients. Expert Opin. Drug Deliv. 4 (2007) 47-61